Global Healthcare Clinical Research Outsourcing Market By Services (Clinical Trials Execution, Statistical Analytics, Pharmacovigilance Services, Regulatory Submissions, Data Management, Medical Writing, Others); By Application (Drug Discovery, Regulatory Affairs, Risk Management, Clinical Trial Phases (Preclinical, Phase I, Phase II, Phase III/ Pivotal, FDA Approval, Others)); By Therapeutic Area (Cardiovascular, Dermatology, Gastroenterology, Oncology, Infectious Diseases, Immunology, Neurology, Urology, Pharmacology, Ophthalmology, Respiratory Diseases, Vaccines, Others); By End Users (Medical Research Centers, Pharmaceutical Manufacturers, Biotechnology Companies, Government Institutions, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In terms of revenue, global healthcare clinical research outsourcing market is growing at an estimated CAGR of 6.98% over the forecast period (2022 – 2030). Research is an integral part of any process where the end result is more of a solution. It is of utmost importance when it is related to healthcare. Healthcare clinical research not only helps in drug discovery but also in finding the root cause of any ailment or disease. In the era of outsourcing, even healthcare clinical research is being outsourced as major pharma and medical research companies are creating a model which helps them streamline processes like medical writing, clinical trials along with regulatory processes. The COVID-19 pandemic which devastated this planet has definitely boosted the growth of the healthcare clinical research outsourcing market. The demand for finding correct and most efficient drug was the need of the hour and pharma companies left no stone unturned to do so. Any work including clinical research was outsourced as the world was and is continuously suffering from the dreadful infection.
Services Outlook
The services segment of the healthcare clinical research outsourcing market has been divided into clinical trials execution, statistical analytics, pharmacovigilance services, regulatory submissions, data management, medical writing, and others. The execution of clinical trials happens to be one of the most important processes when it comes to proving the efficacy and safety of any new drug that is expected to be sent for FDA approval.
Global Healthcare Clinical Research Outsourcing MarketRevenue & Forecast, (US$ Million), 2015 – 2030
Application Outlook
The application segment of the global healthcare clinical research outsourcing market has been bifurcated into drug discovery, clinical trial phases, regulatory affairs, risk management and others. The clinical trial phases segment which dominated in terms of market share in 2021 is further segregated in preclinical, phase I, phase II, phase III/pivotal and FDA approval. The clinical trial phases are where the future of any drug or medication is decided and hence most importance is given to this phase when it comes to outsourcing.
Therapeutic Area Outlook
On the basis of therapeutic area, the global healthcare clinical research outsourcing market has been divided into cardiovascular, dermatology, gastroenterology, oncology, infectious diseases, immunology, neurology, urology, pharmacology, ophthalmology, respiratory diseases, vaccines and others. The number of people suffering from malignant tumors and cancer are at an all-time high and this is exactly why the oncology segment generates maximum money for this market.
End Users Outlook
The end users’ segment of the global healthcare clinical research outsourcing market has been segmented into medical research centers, pharmaceutical manufacturers, biotechnology companies, government institutions, and others. Finding treatment for any new disease or even of which the cure hasn’t been found yet is extremely important and this is basically why medical research centers account for majority of revenue generated by this segment.
Region Outlook
On the basis of region, North America constituted for the maximum revenue of the global healthcare clinical research outsourcing market in 2021. Top pharma and medical research companies are keen on discovery of new drugs for ailments that urgently require effective treatment. These companies are willing to spend huge amounts on outsourcing clinical research and this is the reason behind this region’s dominance.
Competitive Landscape
The report provides both, qualitative and quantitative research of global healthcare clinical research outsourcing market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the Global Healthcare Clinical Research Outsourcing Market are listed below:
- Accell Clinical Research, LLC
- CMIC Holdings Co, LTD.
- Covance Inc.
- ICON plc
- IQVIA Inc.
- Javara
- KCR S.A.
- Marietta Eye Clinic.
- Parexel International Corporation
- PPD Inc.
- PSI
- Syneos Health
- WuXi AppTec
- Other Market Participants
Global Healthcare Clinical Research Outsourcing Market
By Services
- Clinical Trials Execution
- Statistical Analytics
- Pharmacovigilance Services
- Regulatory Submissions
- Data Management
- Medical Writing
- Others
By Application
- Drug Discovery
- Clinical Trial Phases
- Preclinical
- Phase I
- Phase II
- Phase III/ Pivotal
- FDA Approval
- Regulatory Affairs
- Risk Management
- Others
By Therapeutic Area
- Cardiovascular
- Dermatology
- Gastroenterology
- Oncology
- Infectious Diseases
- Immunology
- Neurology
- Urology
- Pharmacology
- Ophthalmology
- Respiratory Diseases
- Vaccines
- Others
By End Users
- Medical Research Centers
- Pharmaceutical Manufacturers
- Biotechnology Companies
- Government Institutions
- Others
By Region
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Healthcare Clinical Research Outsourcing Market
6.
Market
Synopsis: Healthcare Clinical Research
Outsourcing Market
7.
Healthcare
Clinical Research Outsourcing Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Healthcare Clinical Research
Outsourcing Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Healthcare Clinical Research Outsourcing Market
7.6. Impact of Covid-19 on Healthcare Clinical
Research Outsourcing Market
8.
Global
Healthcare Clinical Research Outsourcing Market Analysis and Forecasts, 2022 –
2030
8.1. Overview
8.1.1. Global Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn)
8.2. Global Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
8.2.1. Clinical Trials Execution
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 -
2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. Statistical Analytics
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 -
2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.2.3. Pharmacovigilance Services
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 -
2021
8.2.3.3. Market Forecast, 2022 – 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 – 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 – 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 – 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 – 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 – 2030
8.2.4. Regulatory Submissions
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 -
2021
8.2.4.3. Market Forecast, 2022 – 2030
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market Estimation, 2015 - 2021
8.2.4.5.1.2. Market Forecast, 2022 – 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2021
8.2.4.5.2.2. Market Forecast, 2022 – 2030
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2021
8.2.4.5.3.2. Market Forecast, 2022 – 2030
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2021
8.2.4.5.4.2. Market Forecast, 2022 – 2030
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market Estimation, 2015 - 2021
8.2.4.5.5.2. Market Forecast, 2022 – 2030
8.2.5. Data Management
8.2.5.1. Definition
8.2.5.2. Market Estimation and Penetration, 2015 -
2021
8.2.5.3. Market Forecast, 2022 – 2030
8.2.5.4. Compound Annual Growth Rate (CAGR)
8.2.5.5. Regional Bifurcation
8.2.5.5.1. North America
8.2.5.5.1.1. Market Estimation, 2015 - 2021
8.2.5.5.1.2. Market Forecast, 2022 – 2030
8.2.5.5.2. Europe
8.2.5.5.2.1. Market Estimation, 2015 - 2021
8.2.5.5.2.2. Market Forecast, 2022 – 2030
8.2.5.5.3. Asia Pacific
8.2.5.5.3.1. Market Estimation, 2015 - 2021
8.2.5.5.3.2. Market Forecast, 2022 – 2030
8.2.5.5.4. Middle East and Africa
8.2.5.5.4.1. Market Estimation, 2015 - 2021
8.2.5.5.4.2. Market Forecast, 2022 – 2030
8.2.5.5.5. Latin America
8.2.5.5.5.1. Market Estimation, 2015 - 2021
8.2.5.5.5.2. Market Forecast, 2022 – 2030
8.2.6. Medical Writing
8.2.6.1. Definition
8.2.6.2. Market Estimation and Penetration, 2015 -
2021
8.2.6.3. Market Forecast, 2022 – 2030
8.2.6.4. Compound Annual Growth Rate (CAGR)
8.2.6.5. Regional Bifurcation
8.2.6.5.1. North America
8.2.6.5.1.1. Market Estimation, 2015 - 2021
8.2.6.5.1.2. Market Forecast, 2022 – 2030
8.2.6.5.2. Europe
8.2.6.5.2.1. Market Estimation, 2015 - 2021
8.2.6.5.2.2. Market Forecast, 2022 – 2030
8.2.6.5.3. Asia Pacific
8.2.6.5.3.1. Market Estimation, 2015 - 2021
8.2.6.5.3.2. Market Forecast, 2022 – 2030
8.2.6.5.4. Middle East and Africa
8.2.6.5.4.1. Market Estimation, 2015 - 2021
8.2.6.5.4.2. Market Forecast, 2022 – 2030
8.2.6.5.5. Latin America
8.2.6.5.5.1. Market Estimation, 2015 - 2021
8.2.6.5.5.2. Market Forecast, 2022 – 2030
8.2.7. Others
8.2.7.1. Definition
8.2.7.2. Market Estimation and Penetration, 2015 -
2021
8.2.7.3. Market Forecast, 2022 – 2030
8.2.7.4. Compound Annual Growth Rate (CAGR)
8.2.7.5. Regional Bifurcation
8.2.7.5.1. North America
8.2.7.5.1.1. Market Estimation, 2015 - 2021
8.2.7.5.1.2. Market Forecast, 2022 – 2030
8.2.7.5.2. Europe
8.2.7.5.2.1. Market Estimation, 2015 - 2021
8.2.7.5.2.2. Market Forecast, 2022 – 2030
8.2.7.5.3. Asia Pacific
8.2.7.5.3.1. Market Estimation, 2015 - 2021
8.2.7.5.3.2. Market Forecast, 2022 – 2030
8.2.7.5.4. Middle East and Africa
8.2.7.5.4.1. Market Estimation, 2015 - 2021
8.2.7.5.4.2. Market Forecast, 2022 – 2030
8.2.7.5.5. Latin America
8.2.7.5.5.1. Market Estimation, 2015 - 2021
8.2.7.5.5.2. Market Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Services
9.
Global
Healthcare Clinical Research Outsourcing Market Analysis and Forecasts, 2022 –
2030
9.1. Overview
9.2. Global Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Drug Discovery
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 -
2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Clinical Trial Phases (Definition, Market
Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021),
Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation
(North America, Europe, Asia Pacific, Middle East and Africa, Latin America)
and Information on Preclinical, Phase I, Phase II, Phase III/ Pivotal, FDA
Approval)
9.2.2.1. Preclinical
9.2.2.2. Phase I
9.2.2.3. Phase II
9.2.2.4. Phase III/ Pivotal
9.2.2.5. FDA Approval
9.2.3. Regulatory Affairs
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 -
2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.2.4. Risk
Management
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 -
2021
9.2.4.3. Market Forecast, 2022 – 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 – 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 – 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 – 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 – 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 – 2030
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 -
2021
9.2.5.3. Market Forecast, 2022 – 2030
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market Estimation, 2015 - 2021
9.2.5.5.1.2. Market Forecast, 2022 – 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2021
9.2.5.5.2.2. Market Forecast, 2022 – 2030
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2021
9.2.5.5.3.2. Market Forecast, 2022 – 2030
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2021
9.2.5.5.4.2. Market Forecast, 2022 – 2030
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market Estimation, 2015 - 2021
9.2.5.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Application
10. Global Healthcare Clinical Research
Outsourcing Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
10.2.1. Cardiovascular
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 -
2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Dermatology
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 -
2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Gastroenterology
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 -
2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.2.4. Oncology
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 -
2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 – 2030
10.2.5. Infectious Diseases
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 -
2021
10.2.5.3. Market Forecast, 2022 – 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 – 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 – 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 – 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 – 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 – 2030
10.2.6. Immunology
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 -
2021
10.2.6.3. Market Forecast, 2022 – 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market Estimation, 2015 - 2021
10.2.6.5.1.2. Market Forecast, 2022 – 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market Estimation, 2015 - 2021
10.2.6.5.2.2. Market Forecast, 2022 – 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market Estimation, 2015 - 2021
10.2.6.5.3.2. Market Forecast, 2022 – 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market Estimation, 2015 - 2021
10.2.6.5.4.2. Market Forecast, 2022 – 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market Estimation, 2015 - 2021
10.2.6.5.5.2. Market Forecast, 2022 – 2030
10.2.7. Neurology
10.2.7.1. Definition
10.2.7.2. Market Estimation and Penetration, 2015 -
2021
10.2.7.3. Market Forecast, 2022 – 2030
10.2.7.4. Compound Annual Growth Rate (CAGR)
10.2.7.5. Regional Bifurcation
10.2.7.5.1. North America
10.2.7.5.1.1. Market Estimation, 2015 - 2021
10.2.7.5.1.2. Market Forecast, 2022 – 2030
10.2.7.5.2. Europe
10.2.7.5.2.1. Market Estimation, 2015 - 2021
10.2.7.5.2.2. Market Forecast, 2022 – 2030
10.2.7.5.3. Asia Pacific
10.2.7.5.3.1. Market Estimation, 2015 - 2021
10.2.7.5.3.2. Market Forecast, 2022 – 2030
10.2.7.5.4. Middle East and Africa
10.2.7.5.4.1. Market Estimation, 2015 - 2021
10.2.7.5.4.2. Market Forecast, 2022 – 2030
10.2.7.5.5. Latin America
10.2.7.5.5.1. Market Estimation, 2015 - 2021
10.2.7.5.5.2. Market Forecast, 2022 – 2030
10.2.8. Urology
10.2.8.1. Definition
10.2.8.2. Market Estimation and Penetration, 2015 -
2021
10.2.8.3. Market Forecast, 2022 – 2030
10.2.8.4. Compound Annual Growth Rate (CAGR)
10.2.8.5. Regional Bifurcation
10.2.8.5.1. North America
10.2.8.5.1.1. Market Estimation, 2015 - 2021
10.2.8.5.1.2. Market Forecast, 2022 – 2030
10.2.8.5.2. Europe
10.2.8.5.2.1. Market Estimation, 2015 - 2021
10.2.8.5.2.2. Market Forecast, 2022 – 2030
10.2.8.5.3. Asia Pacific
10.2.8.5.3.1. Market Estimation, 2015 - 2021
10.2.8.5.3.2. Market Forecast, 2022 – 2030
10.2.8.5.4. Middle East and Africa
10.2.8.5.4.1. Market Estimation, 2015 - 2021
10.2.8.5.4.2. Market Forecast, 2022 – 2030
10.2.8.5.5. Latin America
10.2.8.5.5.1. Market Estimation, 2015 - 2021
10.2.8.5.5.2. Market Forecast, 2022 – 2030
10.2.9. Pharmacology
10.2.9.1. Definition
10.2.9.2. Market Estimation and Penetration, 2015 -
2021
10.2.9.3. Market Forecast, 2022 – 2030
10.2.9.4. Compound Annual Growth Rate (CAGR)
10.2.9.5. Regional Bifurcation
10.2.9.5.1. North America
10.2.9.5.1.1. Market Estimation, 2015 - 2021
10.2.9.5.1.2. Market Forecast, 2022 – 2030
10.2.9.5.2. Europe
10.2.9.5.2.1. Market Estimation, 2015 - 2021
10.2.9.5.2.2. Market Forecast, 2022 – 2030
10.2.9.5.3. Asia Pacific
10.2.9.5.3.1. Market Estimation, 2015 - 2021
10.2.9.5.3.2. Market Forecast, 2022 – 2030
10.2.9.5.4. Middle East and Africa
10.2.9.5.4.1. Market Estimation, 2015 - 2021
10.2.9.5.4.2. Market Forecast, 2022 – 2030
10.2.9.5.5. Latin America
10.2.9.5.5.1. Market Estimation, 2015 - 2021
10.2.9.5.5.2. Market Forecast, 2022 – 2030
10.2.10. Ophthalmology
10.2.10.1. Definition
10.2.10.2. Market Estimation and Penetration, 2015 -
2021
10.2.10.3. Market Forecast, 2022 – 2030
10.2.10.4. Compound Annual Growth Rate (CAGR)
10.2.10.5. Regional Bifurcation
10.2.10.5.1. North America
10.2.10.5.1.1. Market Estimation, 2015 - 2021
10.2.10.5.1.2. Market Forecast, 2022 – 2030
10.2.10.5.2. Europe
10.2.10.5.2.1. Market Estimation, 2015 - 2021
10.2.10.5.2.2. Market Forecast, 2022 – 2030
10.2.10.5.3. Asia Pacific
10.2.10.5.3.1. Market Estimation, 2015 - 2021
10.2.10.5.3.2. Market Forecast, 2022 – 2030
10.2.10.5.4. Middle East and Africa
10.2.10.5.4.1. Market Estimation, 2015 - 2021
10.2.10.5.4.2. Market Forecast, 2022 – 2030
10.2.10.5.5. Latin America
10.2.10.5.5.1. Market Estimation, 2015 - 2021
10.2.10.5.5.2. Market Forecast, 2022 – 2030
10.2.11. Respiratory Diseases
10.2.11.1. Definition
10.2.11.2. Market Estimation and Penetration, 2015 -
2021
10.2.11.3. Market Forecast, 2022 – 2030
10.2.11.4. Compound Annual Growth Rate (CAGR)
10.2.11.5. Regional Bifurcation
10.2.11.5.1. North America
10.2.11.5.1.1. Market Estimation, 2015 - 2021
10.2.11.5.1.2. Market Forecast, 2022 – 2030
10.2.11.5.2. Europe
10.2.11.5.2.1. Market Estimation, 2015 - 2021
10.2.11.5.2.2. Market Forecast, 2022 – 2030
10.2.11.5.3. Asia Pacific
10.2.11.5.3.1. Market Estimation, 2015 - 2021
10.2.11.5.3.2. Market Forecast, 2022 – 2030
10.2.11.5.4. Middle East and Africa
10.2.11.5.4.1. Market Estimation, 2015 - 2021
10.2.11.5.4.2. Market Forecast, 2022 – 2030
10.2.11.5.5. Latin America
10.2.11.5.5.1. Market Estimation, 2015 - 2021
10.2.11.5.5.2. Market Forecast, 2022 – 2030
10.2.12. Vaccines
10.2.12.1. Definition
10.2.12.2. Market Estimation and Penetration, 2015 -
2021
10.2.12.3. Market Forecast, 2022 – 2030
10.2.12.4. Compound Annual Growth Rate (CAGR)
10.2.12.5. Regional Bifurcation
10.2.12.5.1. North America
10.2.12.5.1.1. Market Estimation, 2015 - 2021
10.2.12.5.1.2. Market Forecast, 2022 – 2030
10.2.12.5.2. Europe
10.2.12.5.2.1. Market Estimation, 2015 - 2021
10.2.12.5.2.2. Market Forecast, 2022 – 2030
10.2.12.5.3. Asia Pacific
10.2.12.5.3.1. Market Estimation, 2015 - 2021
10.2.12.5.3.2. Market Forecast, 2022 – 2030
10.2.12.5.4. Middle East and Africa
10.2.12.5.4.1. Market Estimation, 2015 - 2021
10.2.12.5.4.2. Market Forecast, 2022 – 2030
10.2.12.5.5. Latin America
10.2.12.5.5.1. Market Estimation, 2015 - 2021
10.2.12.5.5.2. Market Forecast, 2022 – 2030
10.2.13. Others
10.2.13.1. Definition
10.2.13.2. Market Estimation and Penetration, 2015 -
2021
10.2.13.3. Market Forecast, 2022 – 2030
10.2.13.4. Compound Annual Growth Rate (CAGR)
10.2.13.5. Regional Bifurcation
10.2.13.5.1. North America
10.2.13.5.1.1. Market Estimation, 2015 - 2021
10.2.13.5.1.2. Market Forecast, 2022 – 2030
10.2.13.5.2. Europe
10.2.13.5.2.1. Market Estimation, 2015 - 2021
10.2.13.5.2.2. Market Forecast, 2022 – 2030
10.2.13.5.3. Asia Pacific
10.2.13.5.3.1. Market Estimation, 2015 - 2021
10.2.13.5.3.2. Market Forecast, 2022 – 2030
10.2.13.5.4. Middle East and Africa
10.2.13.5.4.1. Market Estimation, 2015 - 2021
10.2.13.5.4.2. Market Forecast, 2022 – 2030
10.2.13.5.5. Latin America
10.2.13.5.5.1. Market Estimation, 2015 - 2021
10.2.13.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Therapeutic Area
11. Global Healthcare Clinical Research
Outsourcing Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Medical Research Centers
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 -
2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Pharmaceutical Manufacturers
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 -
2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Biotechnology Companies
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 -
2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.2.4. Government Institutions
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 -
2021
11.2.4.3. Market Forecast, 2022 – 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 – 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 – 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 – 2030
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 – 2030
11.2.5. Others
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 -
2021
11.2.5.3. Market Forecast, 2022 – 2030
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market Estimation, 2015 - 2021
11.2.5.5.1.2. Market Forecast, 2022 – 2030
11.2.5.5.2. Europe
11.2.5.5.2.1. Market Estimation, 2015 - 2021
11.2.5.5.2.2. Market Forecast, 2022 – 2030
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market Estimation, 2015 - 2021
11.2.5.5.3.2. Market Forecast, 2022 – 2030
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market Estimation, 2015 - 2021
11.2.5.5.4.2. Market Forecast, 2022 – 2030
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market Estimation, 2015 - 2021
11.2.5.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End Users
12. North America Healthcare Clinical Research
Outsourcing Market Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn)
12.2. North America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
12.2.1. Clinical Trials Execution
12.2.2. Statistical Analytics
12.2.3. Pharmacovigilance Services
12.2.4. Regulatory Submissions
12.2.5. Data Management
12.2.6. Medical Writing
12.2.7. Others
12.3. North America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Drug Discovery
12.3.2. Clinical Trial Phases
12.3.2.1. Preclinical
12.3.2.2. Phase I
12.3.2.3. Phase II
12.3.2.4. Phase III/ Pivotal
12.3.2.5. FDA Approval
12.3.3. Regulatory Affairs
12.3.4. Risk
Management
12.3.5. Others
12.4. North America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.4.1. Cardiovascular
12.4.2. Dermatology
12.4.3. Gastroenterology
12.4.4. Oncology
12.4.5. Infectious Diseases
12.4.6. Immunology
12.4.7. Neurology
12.4.8. Urology
12.4.9. Pharmacology
12.4.10. Ophthalmology
12.4.11. Respiratory Diseases
12.4.12. Vaccines
12.4.13. Others
12.5. North America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Medical Research Centers
12.5.2. Pharmaceutical Manufacturers
12.5.3. Biotechnology Companies
12.5.4. Government Institutions
12.5.5. Others
12.6. North America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Healthcare Clinical Research Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Services
12.6.1.1.1. Clinical Trials Execution
12.6.1.1.2. Statistical Analytics
12.6.1.1.3. Pharmacovigilance Services
12.6.1.1.4. Regulatory Submissions
12.6.1.1.5. Data Management
12.6.1.1.6. Medical Writing
12.6.1.1.7. Others
12.6.1.2. U.S Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.2.1. Drug Discovery
12.6.1.2.2. Clinical Trial Phases
12.6.1.2.2.1. Preclinical
12.6.1.2.2.2. Phase I
12.6.1.2.2.3. Phase II
12.6.1.2.2.4. Phase III/ Pivotal
12.6.1.2.2.5. FDA Approval
12.6.1.2.3. Regulatory Affairs
12.6.1.2.4. Risk
Management
12.6.1.2.5. Others
12.6.1.3. U.S Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.6.1.3.1. Cardiovascular
12.6.1.3.2. Dermatology
12.6.1.3.3. Gastroenterology
12.6.1.3.4. Oncology
12.6.1.3.5. Infectious Diseases
12.6.1.3.6. Immunology
12.6.1.3.7. Neurology
12.6.1.3.8. Urology
12.6.1.3.9. Pharmacology
12.6.1.3.10. Ophthalmology
12.6.1.3.11. Respiratory Diseases
12.6.1.3.12. Vaccines
12.6.1.3.13. Others
12.6.1.4. U.S Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.1.4.1. Medical Research Centers
12.6.1.4.2. Pharmaceutical Manufacturers
12.6.1.4.3. Biotechnology Companies
12.6.1.4.4. Government Institutions
12.6.1.4.5. Others
12.6.2. Canada
12.6.2.1. Canada Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
12.6.2.1.1. Clinical Trials Execution
12.6.2.1.2. Statistical Analytics
12.6.2.1.3. Pharmacovigilance Services
12.6.2.1.4. Regulatory Submissions
12.6.2.1.5. Data Management
12.6.2.1.6. Medical Writing
12.6.2.1.7. Others
12.6.2.2. Canada Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.2.1. Drug Discovery
12.6.2.2.2. Clinical Trial Phases
12.6.2.2.2.1. Preclinical
12.6.2.2.2.2. Phase I
12.6.2.2.2.3. Phase II
12.6.2.2.2.4. Phase III/ Pivotal
12.6.2.2.2.5. FDA Approval
12.6.2.2.3. Regulatory Affairs
12.6.2.2.4. Risk
Management
12.6.2.2.5. Others
12.6.2.3. Canada Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.6.2.3.1. Cardiovascular
12.6.2.3.2. Dermatology
12.6.2.3.3. Gastroenterology
12.6.2.3.4. Oncology
12.6.2.3.5. Infectious Diseases
12.6.2.3.6. Immunology
12.6.2.3.7. Neurology
12.6.2.3.8. Urology
12.6.2.3.9. Pharmacology
12.6.2.3.10. Ophthalmology
12.6.2.3.11. Respiratory Diseases
12.6.2.3.12. Vaccines
12.6.2.3.13. Others
12.6.2.4. Canada Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.2.4.1. Medical Research Centers
12.6.2.4.2. Pharmaceutical Manufacturers
12.6.2.4.3. Biotechnology Companies
12.6.2.4.4. Government Institutions
12.6.2.4.5. Others
12.6.3. Mexico
12.6.3.1. Mexico Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
12.6.3.1.1. Clinical Trials Execution
12.6.3.1.2. Statistical Analytics
12.6.3.1.3. Pharmacovigilance Services
12.6.3.1.4. Regulatory Submissions
12.6.3.1.5. Data Management
12.6.3.1.6. Medical Writing
12.6.3.1.7. Others
12.6.3.2. Mexico Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.2.1. Drug Discovery
12.6.3.2.2. Clinical Trial Phases
12.6.3.2.2.1. Preclinical
12.6.3.2.2.2. Phase I
12.6.3.2.2.3. Phase II
12.6.3.2.2.4. Phase III/ Pivotal
12.6.3.2.2.5. FDA Approval
12.6.3.2.3. Regulatory Affairs
12.6.3.2.4. Risk
Management
12.6.3.2.5. Others
12.6.3.3. Mexico Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.6.3.3.1. Cardiovascular
12.6.3.3.2. Dermatology
12.6.3.3.3. Gastroenterology
12.6.3.3.4. Oncology
12.6.3.3.5. Infectious Diseases
12.6.3.3.6. Immunology
12.6.3.3.7. Neurology
12.6.3.3.8. Urology
12.6.3.3.9. Pharmacology
12.6.3.3.10. Ophthalmology
12.6.3.3.11. Respiratory Diseases
12.6.3.3.12. Vaccines
12.6.3.3.13. Others
12.6.3.4. Mexico Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1. Medical Research Centers
12.6.3.4.2. Pharmaceutical Manufacturers
12.6.3.4.3. Biotechnology Companies
12.6.3.4.4. Government Institutions
12.6.3.4.5. Others
12.6.4. Rest of North America
12.6.4.1. Rest of North America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
12.6.4.1.1. Clinical Trials Execution
12.6.4.1.2. Statistical Analytics
12.6.4.1.3. Pharmacovigilance Services
12.6.4.1.4. Regulatory Submissions
12.6.4.1.5. Data Management
12.6.4.1.6. Medical Writing
12.6.4.1.7. Others
12.6.4.2. Rest of North America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.2.1. Drug Discovery
12.6.4.2.2. Clinical Trial Phases
12.6.4.2.2.1. Preclinical
12.6.4.2.2.2. Phase I
12.6.4.2.2.3. Phase II
12.6.4.2.2.4. Phase III/ Pivotal
12.6.4.2.2.5. FDA Approval
12.6.4.2.3. Regulatory Affairs
12.6.4.2.4. Risk
Management
12.6.4.2.5. Others
12.6.4.3. Rest of North America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.6.4.3.1. Cardiovascular
12.6.4.3.2. Dermatology
12.6.4.3.3. Gastroenterology
12.6.4.3.4. Oncology
12.6.4.3.5. Infectious Diseases
12.6.4.3.6. Immunology
12.6.4.3.7. Neurology
12.6.4.3.8. Urology
12.6.4.3.9. Pharmacology
12.6.4.3.10. Ophthalmology
12.6.4.3.11. Respiratory Diseases
12.6.4.3.12. Vaccines
12.6.4.3.13. Others
12.6.4.4. Rest of North America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Medical Research Centers
12.6.4.4.2. Pharmaceutical Manufacturers
12.6.4.4.3. Biotechnology Companies
12.6.4.4.4. Government Institutions
12.6.4.4.5. Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Services
12.7.3. By Application
12.7.4. By Therapeutic Area
12.7.5. By End Users
13. Europe Healthcare Clinical Research
Outsourcing Market Analysis and Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn)
13.2. Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.2.1. Clinical Trials Execution
13.2.2. Statistical Analytics
13.2.3. Pharmacovigilance Services
13.2.4. Regulatory Submissions
13.2.5. Data Management
13.2.6. Medical Writing
13.2.7. Others
13.3. Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Drug Discovery
13.3.2. Clinical Trial Phases
13.3.2.1. Preclinical
13.3.2.2. Phase I
13.3.2.3. Phase II
13.3.2.4. Phase III/ Pivotal
13.3.2.5. FDA Approval
13.3.3. Regulatory Affairs
13.3.4. Risk
Management
13.3.5. Others
13.4. Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.4.1. Cardiovascular
13.4.2. Dermatology
13.4.3. Gastroenterology
13.4.4. Oncology
13.4.5. Infectious Diseases
13.4.6. Immunology
13.4.7. Neurology
13.4.8. Urology
13.4.9. Pharmacology
13.4.10. Ophthalmology
13.4.11. Respiratory Diseases
13.4.12. Vaccines
13.4.13. Others
13.5. Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Medical Research Centers
13.5.2. Pharmaceutical Manufacturers
13.5.3. Biotechnology Companies
13.5.4. Government Institutions
13.5.5. Others
13.6. Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.1.1.1. Clinical Trials Execution
13.6.1.1.2. Statistical Analytics
13.6.1.1.3. Pharmacovigilance Services
13.6.1.1.4. Regulatory Submissions
13.6.1.1.5. Data Management
13.6.1.1.6. Medical Writing
13.6.1.1.7. Others
13.6.1.2. France Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.2.1. Drug Discovery
13.6.1.2.2. Clinical Trial Phases
13.6.1.2.2.1. Preclinical
13.6.1.2.2.2. Phase I
13.6.1.2.2.3. Phase II
13.6.1.2.2.4. Phase III/ Pivotal
13.6.1.2.2.5. FDA Approval
13.6.1.2.3. Regulatory Affairs
13.6.1.2.4. Risk
Management
13.6.1.2.5. Others
13.6.1.3. France Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.1.3.1. Cardiovascular
13.6.1.3.2. Dermatology
13.6.1.3.3. Gastroenterology
13.6.1.3.4. Oncology
13.6.1.3.5. Infectious Diseases
13.6.1.3.6. Immunology
13.6.1.3.7. Neurology
13.6.1.3.8. Urology
13.6.1.3.9. Pharmacology
13.6.1.3.10. Ophthalmology
13.6.1.3.11. Respiratory Diseases
13.6.1.3.12. Vaccines
13.6.1.3.13. Others
13.6.1.4. France Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1. Medical Research Centers
13.6.1.4.2. Pharmaceutical Manufacturers
13.6.1.4.3. Biotechnology Companies
13.6.1.4.4. Government Institutions
13.6.1.4.5. Others
13.6.2. The UK
13.6.2.1. The UK Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.2.1.1. Clinical Trials Execution
13.6.2.1.2. Statistical Analytics
13.6.2.1.3. Pharmacovigilance Services
13.6.2.1.4. Regulatory Submissions
13.6.2.1.5. Data Management
13.6.2.1.6. Medical Writing
13.6.2.1.7. Others
13.6.2.2. The UK Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.2.2.1. Drug Discovery
13.6.2.2.2. Clinical Trial Phases
13.6.2.2.2.1. Preclinical
13.6.2.2.2.2. Phase I
13.6.2.2.2.3. Phase II
13.6.2.2.2.4. Phase III/ Pivotal
13.6.2.2.2.5. FDA Approval
13.6.2.2.3. Regulatory Affairs
13.6.2.2.4. Risk
Management
13.6.2.2.5. Others
13.6.2.3. The UK Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.2.3.1. Cardiovascular
13.6.2.3.2. Dermatology
13.6.2.3.3. Gastroenterology
13.6.2.3.4. Oncology
13.6.2.3.5. Infectious Diseases
13.6.2.3.6. Immunology
13.6.2.3.7. Neurology
13.6.2.3.8. Urology
13.6.2.3.9. Pharmacology
13.6.2.3.10. Ophthalmology
13.6.2.3.11. Respiratory Diseases
13.6.2.3.12. Vaccines
13.6.2.3.13. Others
13.6.2.4. The UK Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.2.4.1. Medical Research Centers
13.6.2.4.2. Pharmaceutical Manufacturers
13.6.2.4.3. Biotechnology Companies
13.6.2.4.4. Government Institutions
13.6.2.4.5. Others
13.6.3. Spain
13.6.3.1. Spain Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.3.1.1. Clinical Trials Execution
13.6.3.1.2. Statistical Analytics
13.6.3.1.3. Pharmacovigilance Services
13.6.3.1.4. Regulatory Submissions
13.6.3.1.5. Data Management
13.6.3.1.6. Medical Writing
13.6.3.1.7. Others
13.6.3.2. Spain Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.2.1. Drug Discovery
13.6.3.2.2. Clinical Trial Phases
13.6.3.2.2.1. Preclinical
13.6.3.2.2.2. Phase I
13.6.3.2.2.3. Phase II
13.6.3.2.2.4. Phase III/ Pivotal
13.6.3.2.2.5. FDA Approval
13.6.3.2.3. Regulatory Affairs
13.6.3.2.4. Risk
Management
13.6.3.2.5. Others
13.6.3.3. Spain Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.3.3.1. Cardiovascular
13.6.3.3.2. Dermatology
13.6.3.3.3. Gastroenterology
13.6.3.3.4. Oncology
13.6.3.3.5. Infectious Diseases
13.6.3.3.6. Immunology
13.6.3.3.7. Neurology
13.6.3.3.8. Urology
13.6.3.3.9. Pharmacology
13.6.3.3.10. Ophthalmology
13.6.3.3.11. Respiratory Diseases
13.6.3.3.12. Vaccines
13.6.3.3.13. Others
13.6.3.4. Spain Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.3.4.1. Medical Research Centers
13.6.3.4.2. Pharmaceutical Manufacturers
13.6.3.4.3. Biotechnology Companies
13.6.3.4.4. Government Institutions
13.6.3.4.5. Others
13.6.4. Germany
13.6.4.1. Germany Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.4.1.1. Clinical Trials Execution
13.6.4.1.2. Statistical Analytics
13.6.4.1.3. Pharmacovigilance Services
13.6.4.1.4. Regulatory Submissions
13.6.4.1.5. Data Management
13.6.4.1.6. Medical Writing
13.6.4.1.7. Others
13.6.4.2. Germany Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.2.1. Drug Discovery
13.6.4.2.2. Clinical Trial Phases
13.6.4.2.2.1. Preclinical
13.6.4.2.2.2. Phase I
13.6.4.2.2.3. Phase II
13.6.4.2.2.4. Phase III/ Pivotal
13.6.4.2.2.5. FDA Approval
13.6.4.2.3. Regulatory Affairs
13.6.4.2.4. Risk
Management
13.6.4.2.5. Others
13.6.4.3. Germany Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.4.3.1. Cardiovascular
13.6.4.3.2. Dermatology
13.6.4.3.3. Gastroenterology
13.6.4.3.4. Oncology
13.6.4.3.5. Infectious Diseases
13.6.4.3.6. Immunology
13.6.4.3.7. Neurology
13.6.4.3.8. Urology
13.6.4.3.9. Pharmacology
13.6.4.3.10. Ophthalmology
13.6.4.3.11. Respiratory Diseases
13.6.4.3.12. Vaccines
13.6.4.3.13. Others
13.6.4.4. Germany Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.4.4.1. Medical Research Centers
13.6.4.4.2. Pharmaceutical Manufacturers
13.6.4.4.3. Biotechnology Companies
13.6.4.4.4. Government Institutions
13.6.4.4.5. Others
13.6.5. Italy
13.6.5.1. Italy Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.5.1.1. Clinical Trials Execution
13.6.5.1.2. Statistical Analytics
13.6.5.1.3. Pharmacovigilance Services
13.6.5.1.4. Regulatory Submissions
13.6.5.1.5. Data Management
13.6.5.1.6. Medical Writing
13.6.5.1.7. Others
13.6.5.2. Italy Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.2.1. Drug Discovery
13.6.5.2.2. Clinical Trial Phases
13.6.5.2.2.1. Preclinical
13.6.5.2.2.2. Phase I
13.6.5.2.2.3. Phase II
13.6.5.2.2.4. Phase III/ Pivotal
13.6.5.2.2.5. FDA Approval
13.6.5.2.3. Regulatory Affairs
13.6.5.2.4. Risk
Management
13.6.5.2.5. Others
13.6.5.3. Italy Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.5.3.1. Cardiovascular
13.6.5.3.2. Dermatology
13.6.5.3.3. Gastroenterology
13.6.5.3.4. Oncology
13.6.5.3.5. Infectious Diseases
13.6.5.3.6. Immunology
13.6.5.3.7. Neurology
13.6.5.3.8. Urology
13.6.5.3.9. Pharmacology
13.6.5.3.10. Ophthalmology
13.6.5.3.11. Respiratory Diseases
13.6.5.3.12. Vaccines
13.6.5.3.13. Others
13.6.5.4. Italy Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.5.4.1. Medical Research Centers
13.6.5.4.2. Pharmaceutical Manufacturers
13.6.5.4.3. Biotechnology Companies
13.6.5.4.4. Government Institutions
13.6.5.4.5. Others
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.6.1.1. Clinical Trials Execution
13.6.6.1.2. Statistical Analytics
13.6.6.1.3. Pharmacovigilance Services
13.6.6.1.4. Regulatory Submissions
13.6.6.1.5. Data Management
13.6.6.1.6. Medical Writing
13.6.6.1.7. Others
13.6.6.2. Nordic Countries Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.2.1. Drug Discovery
13.6.6.2.2. Clinical Trial Phases
13.6.6.2.2.1. Preclinical
13.6.6.2.2.2. Phase I
13.6.6.2.2.3. Phase II
13.6.6.2.2.4. Phase III/ Pivotal
13.6.6.2.2.5. FDA Approval
13.6.6.2.3. Regulatory Affairs
13.6.6.2.4. Risk
Management
13.6.6.2.5. Others
13.6.6.3. Nordic Countries Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.6.3.1. Cardiovascular
13.6.6.3.2. Dermatology
13.6.6.3.3. Gastroenterology
13.6.6.3.4. Oncology
13.6.6.3.5. Infectious Diseases
13.6.6.3.6. Immunology
13.6.6.3.7. Neurology
13.6.6.3.8. Urology
13.6.6.3.9. Pharmacology
13.6.6.3.10. Ophthalmology
13.6.6.3.11. Respiratory Diseases
13.6.6.3.12. Vaccines
13.6.6.3.13. Others
13.6.6.4. Nordic Countries Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1. Medical Research Centers
13.6.6.4.2. Pharmaceutical Manufacturers
13.6.6.4.3. Biotechnology Companies
13.6.6.4.4. Government Institutions
13.6.6.4.5. Others
13.6.6.5. Nordic Countries Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.7.1.1. Clinical Trials Execution
13.6.7.1.2. Statistical Analytics
13.6.7.1.3. Pharmacovigilance Services
13.6.7.1.4. Regulatory Submissions
13.6.7.1.5. Data Management
13.6.7.1.6. Medical Writing
13.6.7.1.7. Others
13.6.7.2. Benelux Union Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.2.1. Drug Discovery
13.6.7.2.2. Clinical Trial Phases
13.6.7.2.2.1. Preclinical
13.6.7.2.2.2. Phase I
13.6.7.2.2.3. Phase II
13.6.7.2.2.4. Phase III/ Pivotal
13.6.7.2.2.5. FDA Approval
13.6.7.2.3. Regulatory Affairs
13.6.7.2.4. Risk
Management
13.6.7.2.5. Others
13.6.7.3. Benelux Union Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.7.3.1. Cardiovascular
13.6.7.3.2. Dermatology
13.6.7.3.3. Gastroenterology
13.6.7.3.4. Oncology
13.6.7.3.5. Infectious Diseases
13.6.7.3.6. Immunology
13.6.7.3.7. Neurology
13.6.7.3.8. Urology
13.6.7.3.9. Pharmacology
13.6.7.3.10. Ophthalmology
13.6.7.3.11. Respiratory Diseases
13.6.7.3.12. Vaccines
13.6.7.3.13. Others
13.6.7.4. Benelux Union Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Medical Research Centers
13.6.7.4.2. Pharmaceutical Manufacturers
13.6.7.4.3. Biotechnology Companies
13.6.7.4.4. Government Institutions
13.6.7.4.5. Others
13.6.7.5. Benelux Union Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
13.6.8.1.1. Clinical Trials Execution
13.6.8.1.2. Statistical Analytics
13.6.8.1.3. Pharmacovigilance Services
13.6.8.1.4. Regulatory Submissions
13.6.8.1.5. Data Management
13.6.8.1.6. Medical Writing
13.6.8.1.7. Others
13.6.8.2. Rest of Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.2.1. Drug Discovery
13.6.8.2.2. Clinical Trial Phases
13.6.8.2.2.1. Preclinical
13.6.8.2.2.2. Phase I
13.6.8.2.2.3. Phase II
13.6.8.2.2.4. Phase III/ Pivotal
13.6.8.2.2.5. FDA Approval
13.6.8.2.3. Regulatory Affairs
13.6.8.2.4. Risk
Management
13.6.8.2.5. Others
13.6.8.3. Rest of Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.6.8.3.1. Cardiovascular
13.6.8.3.2. Dermatology
13.6.8.3.3. Gastroenterology
13.6.8.3.4. Oncology
13.6.8.3.5. Infectious Diseases
13.6.8.3.6. Immunology
13.6.8.3.7. Neurology
13.6.8.3.8. Urology
13.6.8.3.9. Pharmacology
13.6.8.3.10. Ophthalmology
13.6.8.3.11. Respiratory Diseases
13.6.8.3.12. Vaccines
13.6.8.3.13. Others
13.6.8.4. Rest of Europe Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Medical Research Centers
13.6.8.4.2. Pharmaceutical Manufacturers
13.6.8.4.3. Biotechnology Companies
13.6.8.4.4. Government Institutions
13.6.8.4.5. Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Services
13.7.3. By Application
13.7.4. By Therapeutic Area
13.7.5. By End Users
14. Asia Pacific Healthcare Clinical Research
Outsourcing Market Analysis and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn)
14.2. Asia Pacific Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.2.1. Clinical Trials Execution
14.2.2. Statistical Analytics
14.2.3. Pharmacovigilance Services
14.2.4. Regulatory Submissions
14.2.5. Data Management
14.2.6. Medical Writing
14.2.7. Others
14.3. Asia Pacific Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Drug Discovery
14.3.2. Clinical Trial Phases
14.3.2.1. Preclinical
14.3.2.2. Phase I
14.3.2.3. Phase II
14.3.2.4. Phase III/ Pivotal
14.3.2.5. FDA Approval
14.3.3. Regulatory Affairs
14.3.4. Risk
Management
14.3.5. Others
14.4. Asia Pacific Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.4.1. Cardiovascular
14.4.2. Dermatology
14.4.3. Gastroenterology
14.4.4. Oncology
14.4.5. Infectious Diseases
14.4.6. Immunology
14.4.7. Neurology
14.4.8. Urology
14.4.9. Pharmacology
14.4.10. Ophthalmology
14.4.11. Respiratory Diseases
14.4.12. Vaccines
14.4.13. Others
14.5. Asia Pacific Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Medical Research Centers
14.5.2. Pharmaceutical Manufacturers
14.5.3. Biotechnology Companies
14.5.4. Government Institutions
14.5.5. Others
14.6. Asia Pacific Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.1.1.1. Clinical Trials Execution
14.6.1.1.2. Statistical Analytics
14.6.1.1.3. Pharmacovigilance Services
14.6.1.1.4. Regulatory Submissions
14.6.1.1.5. Data Management
14.6.1.1.6. Medical Writing
14.6.1.1.7. Others
14.6.1.2. China Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.2.1. Drug Discovery
14.6.1.2.2. Clinical Trial Phases
14.6.1.2.2.1. Preclinical
14.6.1.2.2.2. Phase I
14.6.1.2.2.3. Phase II
14.6.1.2.2.4. Phase III/ Pivotal
14.6.1.2.2.5. FDA Approval
14.6.1.2.3. Regulatory Affairs
14.6.1.2.4. Risk
Management
14.6.1.2.5. Others
14.6.1.3. China Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.1.3.1. Cardiovascular
14.6.1.3.2. Dermatology
14.6.1.3.3. Gastroenterology
14.6.1.3.4. Oncology
14.6.1.3.5. Infectious Diseases
14.6.1.3.6. Immunology
14.6.1.3.7. Neurology
14.6.1.3.8. Urology
14.6.1.3.9. Pharmacology
14.6.1.3.10. Ophthalmology
14.6.1.3.11. Respiratory Diseases
14.6.1.3.12. Vaccines
14.6.1.3.13. Others
14.6.1.4. China Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1.4.1. Medical Research Centers
14.6.1.4.2. Pharmaceutical Manufacturers
14.6.1.4.3. Biotechnology Companies
14.6.1.4.4. Government Institutions
14.6.1.4.5. Others
14.6.2. Japan
14.6.2.1. Japan Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.2.1.1. Clinical Trials Execution
14.6.2.1.2. Statistical Analytics
14.6.2.1.3. Pharmacovigilance Services
14.6.2.1.4. Regulatory Submissions
14.6.2.1.5. Data Management
14.6.2.1.6. Medical Writing
14.6.2.1.7. Others
14.6.2.2. Japan Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.2.1. Drug Discovery
14.6.2.2.2. Clinical Trial Phases
14.6.2.2.2.1. Preclinical
14.6.2.2.2.2. Phase I
14.6.2.2.2.3. Phase II
14.6.2.2.2.4. Phase III/ Pivotal
14.6.2.2.2.5. FDA Approval
14.6.2.2.3. Regulatory Affairs
14.6.2.2.4. Risk
Management
14.6.2.2.5. Others
14.6.2.3. Japan Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.2.3.1. Cardiovascular
14.6.2.3.2. Dermatology
14.6.2.3.3. Gastroenterology
14.6.2.3.4. Oncology
14.6.2.3.5. Infectious Diseases
14.6.2.3.6. Immunology
14.6.2.3.7. Neurology
14.6.2.3.8. Urology
14.6.2.3.9. Pharmacology
14.6.2.3.10. Ophthalmology
14.6.2.3.11. Respiratory Diseases
14.6.2.3.12. Vaccines
14.6.2.3.13. Others
14.6.2.4. Japan Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.2.4.1. Medical Research Centers
14.6.2.4.2. Pharmaceutical Manufacturers
14.6.2.4.3. Biotechnology Companies
14.6.2.4.4. Government Institutions
14.6.2.4.5. Others
14.6.3. India
14.6.3.1. India Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.3.1.1. Clinical Trials Execution
14.6.3.1.2. Statistical Analytics
14.6.3.1.3. Pharmacovigilance Services
14.6.3.1.4. Regulatory Submissions
14.6.3.1.5. Data Management
14.6.3.1.6. Medical Writing
14.6.3.1.7. Others
14.6.3.2. India Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.2.1. Drug Discovery
14.6.3.2.2. Clinical Trial Phases
14.6.3.2.2.1. Preclinical
14.6.3.2.2.2. Phase I
14.6.3.2.2.3. Phase II
14.6.3.2.2.4. Phase III/ Pivotal
14.6.3.2.2.5. FDA Approval
14.6.3.2.3. Regulatory Affairs
14.6.3.2.4. Risk
Management
14.6.3.2.5. Others
14.6.3.3. India Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.3.3.1. Cardiovascular
14.6.3.3.2. Dermatology
14.6.3.3.3. Gastroenterology
14.6.3.3.4. Oncology
14.6.3.3.5. Infectious Diseases
14.6.3.3.6. Immunology
14.6.3.3.7. Neurology
14.6.3.3.8. Urology
14.6.3.3.9. Pharmacology
14.6.3.3.10. Ophthalmology
14.6.3.3.11. Respiratory Diseases
14.6.3.3.12. Vaccines
14.6.3.3.13. Others
14.6.3.4. India Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.3.4.1. Medical Research Centers
14.6.3.4.2. Pharmaceutical Manufacturers
14.6.3.4.3. Biotechnology Companies
14.6.3.4.4. Government Institutions
14.6.3.4.5. Others
14.6.4. New Zealand
14.6.4.1. New Zealand Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.4.1.1. Clinical Trials Execution
14.6.4.1.2. Statistical Analytics
14.6.4.1.3. Pharmacovigilance Services
14.6.4.1.4. Regulatory Submissions
14.6.4.1.5. Data Management
14.6.4.1.6. Medical Writing
14.6.4.1.7. Others
14.6.4.2. New Zealand Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.2.1. Drug Discovery
14.6.4.2.2. Clinical Trial Phases
14.6.4.2.2.1. Preclinical
14.6.4.2.2.2. Phase I
14.6.4.2.2.3. Phase II
14.6.4.2.2.4. Phase III/ Pivotal
14.6.4.2.2.5. FDA Approval
14.6.4.2.3. Regulatory Affairs
14.6.4.2.4. Risk
Management
14.6.4.2.5. Others
14.6.4.3. New Zealand Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.4.3.1. Cardiovascular
14.6.4.3.2. Dermatology
14.6.4.3.3. Gastroenterology
14.6.4.3.4. Oncology
14.6.4.3.5. Infectious Diseases
14.6.4.3.6. Immunology
14.6.4.3.7. Neurology
14.6.4.3.8. Urology
14.6.4.3.9. Pharmacology
14.6.4.3.10. Ophthalmology
14.6.4.3.11. Respiratory Diseases
14.6.4.3.12. Vaccines
14.6.4.3.13. Others
14.6.4.4. New Zealand Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Medical Research Centers
14.6.4.4.2. Pharmaceutical Manufacturers
14.6.4.4.3. Biotechnology Companies
14.6.4.4.4. Government Institutions
14.6.4.4.5. Others
14.6.5. Australia
14.6.5.1. Australia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.5.1.1. Clinical Trials Execution
14.6.5.1.2. Statistical Analytics
14.6.5.1.3. Pharmacovigilance Services
14.6.5.1.4. Regulatory Submissions
14.6.5.1.5. Data Management
14.6.5.1.6. Medical Writing
14.6.5.1.7. Others
14.6.5.2. Australia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.2.1. Drug Discovery
14.6.5.2.2. Clinical Trial Phases
14.6.5.2.2.1. Preclinical
14.6.5.2.2.2. Phase I
14.6.5.2.2.3. Phase II
14.6.5.2.2.4. Phase III/ Pivotal
14.6.5.2.2.5. FDA Approval
14.6.5.2.3. Regulatory Affairs
14.6.5.2.4. Risk
Management
14.6.5.2.5. Others
14.6.5.3. Australia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.5.3.1. Cardiovascular
14.6.5.3.2. Dermatology
14.6.5.3.3. Gastroenterology
14.6.5.3.4. Oncology
14.6.5.3.5. Infectious Diseases
14.6.5.3.6. Immunology
14.6.5.3.7. Neurology
14.6.5.3.8. Urology
14.6.5.3.9. Pharmacology
14.6.5.3.10. Ophthalmology
14.6.5.3.11. Respiratory Diseases
14.6.5.3.12. Vaccines
14.6.5.3.13. Others
14.6.5.4. Australia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.5.4.1. Medical Research Centers
14.6.5.4.2. Pharmaceutical Manufacturers
14.6.5.4.3. Biotechnology Companies
14.6.5.4.4. Government Institutions
14.6.5.4.5. Others
14.6.6. South Korea
14.6.6.1. South Korea Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.6.1.1. Clinical Trials Execution
14.6.6.1.2. Statistical Analytics
14.6.6.1.3. Pharmacovigilance Services
14.6.6.1.4. Regulatory Submissions
14.6.6.1.5. Data Management
14.6.6.1.6. Medical Writing
14.6.6.1.7. Others
14.6.6.2. South Korea Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.2.1. Drug Discovery
14.6.6.2.2. Clinical Trial Phases
14.6.6.2.2.1. Preclinical
14.6.6.2.2.2. Phase I
14.6.6.2.2.3. Phase II
14.6.6.2.2.4. Phase III/ Pivotal
14.6.6.2.2.5. FDA Approval
14.6.6.2.3. Regulatory Affairs
14.6.6.2.4. Risk
Management
14.6.6.2.5. Others
14.6.6.3. South Korea Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.6.3.1. Cardiovascular
14.6.6.3.2. Dermatology
14.6.6.3.3. Gastroenterology
14.6.6.3.4. Oncology
14.6.6.3.5. Infectious Diseases
14.6.6.3.6. Immunology
14.6.6.3.7. Neurology
14.6.6.3.8. Urology
14.6.6.3.9. Pharmacology
14.6.6.3.10. Ophthalmology
14.6.6.3.11. Respiratory Diseases
14.6.6.3.12. Vaccines
14.6.6.3.13. Others
14.6.6.4. South Korea Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Medical Research Centers
14.6.6.4.2. Pharmaceutical Manufacturers
14.6.6.4.3. Biotechnology Companies
14.6.6.4.4. Government Institutions
14.6.6.4.5. Others
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.7.1.1. Clinical Trials Execution
14.6.7.1.2. Statistical Analytics
14.6.7.1.3. Pharmacovigilance Services
14.6.7.1.4. Regulatory Submissions
14.6.7.1.5. Data Management
14.6.7.1.6. Medical Writing
14.6.7.1.7. Others
14.6.7.2. Southeast Asia Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.2.1. Drug Discovery
14.6.7.2.2. Clinical Trial Phases
14.6.7.2.2.1. Preclinical
14.6.7.2.2.2. Phase I
14.6.7.2.2.3. Phase II
14.6.7.2.2.4. Phase III/ Pivotal
14.6.7.2.2.5. FDA Approval
14.6.7.2.3. Regulatory Affairs
14.6.7.2.4. Risk
Management
14.6.7.2.5. Others
14.6.7.3. Southeast Asia Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.7.3.1. Cardiovascular
14.6.7.3.2. Dermatology
14.6.7.3.3. Gastroenterology
14.6.7.3.4. Oncology
14.6.7.3.5. Infectious Diseases
14.6.7.3.6. Immunology
14.6.7.3.7. Neurology
14.6.7.3.8. Urology
14.6.7.3.9. Pharmacology
14.6.7.3.10. Ophthalmology
14.6.7.3.11. Respiratory Diseases
14.6.7.3.12. Vaccines
14.6.7.3.13. Others
14.6.7.4. Southeast Asia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Medical Research Centers
14.6.7.4.2. Pharmaceutical Manufacturers
14.6.7.4.3. Biotechnology Companies
14.6.7.4.4. Government Institutions
14.6.7.4.5. Others
14.6.7.5. Southeast Asia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
14.6.8.1.1. Clinical Trials Execution
14.6.8.1.2. Statistical Analytics
14.6.8.1.3. Pharmacovigilance Services
14.6.8.1.4. Regulatory Submissions
14.6.8.1.5. Data Management
14.6.8.1.6. Medical Writing
14.6.8.1.7. Others
14.6.8.2. Rest of Asia Pacific Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
14.6.8.2.1. Drug Discovery
14.6.8.2.2. Clinical Trial Phases
14.6.8.2.2.1. Preclinical
14.6.8.2.2.2. Phase I
14.6.8.2.2.3. Phase II
14.6.8.2.2.4. Phase III/ Pivotal
14.6.8.2.2.5. FDA Approval
14.6.8.2.3. Regulatory Affairs
14.6.8.2.4. Risk
Management
14.6.8.2.5. Others
14.6.8.3. Rest of Asia Pacific Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.6.8.3.1. Cardiovascular
14.6.8.3.2. Dermatology
14.6.8.3.3. Gastroenterology
14.6.8.3.4. Oncology
14.6.8.3.5. Infectious Diseases
14.6.8.3.6. Immunology
14.6.8.3.7. Neurology
14.6.8.3.8. Urology
14.6.8.3.9. Pharmacology
14.6.8.3.10. Ophthalmology
14.6.8.3.11. Respiratory Diseases
14.6.8.3.12. Vaccines
14.6.8.3.13. Others
14.6.8.4. Rest of Asia Pacific Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Medical Research Centers
14.6.8.4.2. Pharmaceutical Manufacturers
14.6.8.4.3. Biotechnology Companies
14.6.8.4.4. Government Institutions
14.6.8.4.5. Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Services
14.7.3. By Application
14.7.4. By Therapeutic Area
14.7.5. By End Users
15. Middle East and Africa Healthcare Clinical
Research Outsourcing Market Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn)
15.2. Middle East and Africa Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
15.2.1. Clinical Trials Execution
15.2.2. Statistical Analytics
15.2.3. Pharmacovigilance Services
15.2.4. Regulatory Submissions
15.2.5. Data Management
15.2.6. Medical Writing
15.2.7. Others
15.3. Middle East and Africa Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1. Drug Discovery
15.3.2. Clinical Trial Phases
15.3.2.1. Preclinical
15.3.2.2. Phase I
15.3.2.3. Phase II
15.3.2.4. Phase III/ Pivotal
15.3.2.5. FDA Approval
15.3.3. Regulatory Affairs
15.3.4. Risk
Management
15.3.5. Others
15.4. Middle East and Africa Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.4.1. Cardiovascular
15.4.2. Dermatology
15.4.3. Gastroenterology
15.4.4. Oncology
15.4.5. Infectious Diseases
15.4.6. Immunology
15.4.7. Neurology
15.4.8. Urology
15.4.9. Pharmacology
15.4.10. Ophthalmology
15.4.11. Respiratory Diseases
15.4.12. Vaccines
15.4.13. Others
15.5. Middle East and Africa Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Medical Research Centers
15.5.2. Pharmaceutical Manufacturers
15.5.3. Biotechnology Companies
15.5.4. Government Institutions
15.5.5. Others
15.6. Middle East and Africa Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
15.6.1.1.1. Clinical Trials Execution
15.6.1.1.2. Statistical Analytics
15.6.1.1.3. Pharmacovigilance Services
15.6.1.1.4. Regulatory Submissions
15.6.1.1.5. Data Management
15.6.1.1.6. Medical Writing
15.6.1.1.7. Others
15.6.1.2. Saudi Arabia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.2.1. Drug Discovery
15.6.1.2.2. Clinical Trial Phases
15.6.1.2.2.1. Preclinical
15.6.1.2.2.2. Phase I
15.6.1.2.2.3. Phase II
15.6.1.2.2.4. Phase III/ Pivotal
15.6.1.2.2.5. FDA Approval
15.6.1.2.3. Regulatory Affairs
15.6.1.2.4. Risk
Management
15.6.1.2.5. Others
15.6.1.3. Saudi Arabia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.6.1.3.1. Cardiovascular
15.6.1.3.2. Dermatology
15.6.1.3.3. Gastroenterology
15.6.1.3.4. Oncology
15.6.1.3.5. Infectious Diseases
15.6.1.3.6. Immunology
15.6.1.3.7. Neurology
15.6.1.3.8. Urology
15.6.1.3.9. Pharmacology
15.6.1.3.10. Ophthalmology
15.6.1.3.11. Respiratory Diseases
15.6.1.3.12. Vaccines
15.6.1.3.13. Others
15.6.1.4. Saudi Arabia Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Medical Research Centers
15.6.1.4.2. Pharmaceutical Manufacturers
15.6.1.4.3. Biotechnology Companies
15.6.1.4.4. Government Institutions
15.6.1.4.5. Others
15.6.2. UAE
15.6.2.1. UAE Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Services
15.6.2.1.1. Clinical Trials Execution
15.6.2.1.2. Statistical Analytics
15.6.2.1.3. Pharmacovigilance Services
15.6.2.1.4. Regulatory Submissions
15.6.2.1.5. Data Management
15.6.2.1.6. Medical Writing
15.6.2.1.7. Others
15.6.2.2. UAE Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.2.1. Drug Discovery
15.6.2.2.2. Clinical Trial Phases
15.6.2.2.2.1. Preclinical
15.6.2.2.2.2. Phase I
15.6.2.2.2.3. Phase II
15.6.2.2.2.4. Phase III/ Pivotal
15.6.2.2.2.5. FDA Approval
15.6.2.2.3. Regulatory Affairs
15.6.2.2.4. Risk
Management
15.6.2.2.5. Others
15.6.2.3. UAE Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.6.2.3.1. Cardiovascular
15.6.2.3.2. Dermatology
15.6.2.3.3. Gastroenterology
15.6.2.3.4. Oncology
15.6.2.3.5. Infectious Diseases
15.6.2.3.6. Immunology
15.6.2.3.7. Neurology
15.6.2.3.8. Urology
15.6.2.3.9. Pharmacology
15.6.2.3.10. Ophthalmology
15.6.2.3.11. Respiratory Diseases
15.6.2.3.12. Vaccines
15.6.2.3.13. Others
15.6.2.4. UAE Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.2.4.1. Medical Research Centers
15.6.2.4.2. Pharmaceutical Manufacturers
15.6.2.4.3. Biotechnology Companies
15.6.2.4.4. Government Institutions
15.6.2.4.5. Others
15.6.3. Egypt
15.6.3.1. Egypt Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
15.6.3.1.1. Clinical Trials Execution
15.6.3.1.2. Statistical Analytics
15.6.3.1.3. Pharmacovigilance Services
15.6.3.1.4. Regulatory Submissions
15.6.3.1.5. Data Management
15.6.3.1.6. Medical Writing
15.6.3.1.7. Others
15.6.3.2. Egypt Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.2.1. Drug Discovery
15.6.3.2.2. Clinical Trial Phases
15.6.3.2.2.1. Preclinical
15.6.3.2.2.2. Phase I
15.6.3.2.2.3. Phase II
15.6.3.2.2.4. Phase III/ Pivotal
15.6.3.2.2.5. FDA Approval
15.6.3.2.3. Regulatory Affairs
15.6.3.2.4. Risk
Management
15.6.3.2.5. Others
15.6.3.3. Egypt Healthcare Clinical Research Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.6.3.3.1. Cardiovascular
15.6.3.3.2. Dermatology
15.6.3.3.3. Gastroenterology
15.6.3.3.4. Oncology
15.6.3.3.5. Infectious Diseases
15.6.3.3.6. Immunology
15.6.3.3.7. Neurology
15.6.3.3.8. Urology
15.6.3.3.9. Pharmacology
15.6.3.3.10. Ophthalmology
15.6.3.3.11. Respiratory Diseases
15.6.3.3.12. Vaccines
15.6.3.3.13. Others
15.6.3.4. Egypt Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.3.4.1. Medical Research Centers
15.6.3.4.2. Pharmaceutical Manufacturers
15.6.3.4.3. Biotechnology Companies
15.6.3.4.4. Government Institutions
15.6.3.4.5. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
15.6.4.1.1. Clinical Trials Execution
15.6.4.1.2. Statistical Analytics
15.6.4.1.3. Pharmacovigilance Services
15.6.4.1.4. Regulatory Submissions
15.6.4.1.5. Data Management
15.6.4.1.6. Medical Writing
15.6.4.1.7. Others
15.6.4.2. Kuwait Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.2.1. Drug Discovery
15.6.4.2.2. Clinical Trial Phases
15.6.4.2.2.1. Preclinical
15.6.4.2.2.2. Phase I
15.6.4.2.2.3. Phase II
15.6.4.2.2.4. Phase III/ Pivotal
15.6.4.2.2.5. FDA Approval
15.6.4.2.3. Regulatory Affairs
15.6.4.2.4. Risk
Management
15.6.4.2.5. Others
15.6.4.3. Kuwait Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.6.4.3.1. Cardiovascular
15.6.4.3.2. Dermatology
15.6.4.3.3. Gastroenterology
15.6.4.3.4. Oncology
15.6.4.3.5. Infectious Diseases
15.6.4.3.6. Immunology
15.6.4.3.7. Neurology
15.6.4.3.8. Urology
15.6.4.3.9. Pharmacology
15.6.4.3.10. Ophthalmology
15.6.4.3.11. Respiratory Diseases
15.6.4.3.12. Vaccines
15.6.4.3.13. Others
15.6.4.4. Kuwait Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.4.4.1. Medical Research Centers
15.6.4.4.2. Pharmaceutical Manufacturers
15.6.4.4.3. Biotechnology Companies
15.6.4.4.4. Government Institutions
15.6.4.4.5. Others
15.6.5. South Africa
15.6.5.1. South Africa Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
15.6.5.1.1. Clinical Trials Execution
15.6.5.1.2. Statistical Analytics
15.6.5.1.3. Pharmacovigilance Services
15.6.5.1.4. Regulatory Submissions
15.6.5.1.5. Data Management
15.6.5.1.6. Medical Writing
15.6.5.1.7. Others
15.6.5.2. South Africa Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.2.1. Drug Discovery
15.6.5.2.2. Clinical Trial Phases
15.6.5.2.2.1. Preclinical
15.6.5.2.2.2. Phase I
15.6.5.2.2.3. Phase II
15.6.5.2.2.4. Phase III/ Pivotal
15.6.5.2.2.5. FDA Approval
15.6.5.2.3. Regulatory Affairs
15.6.5.2.4. Risk
Management
15.6.5.2.5. Others
15.6.5.3. South Africa Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.6.5.3.1. Cardiovascular
15.6.5.3.2. Dermatology
15.6.5.3.3. Gastroenterology
15.6.5.3.4. Oncology
15.6.5.3.5. Infectious Diseases
15.6.5.3.6. Immunology
15.6.5.3.7. Neurology
15.6.5.3.8. Urology
15.6.5.3.9. Pharmacology
15.6.5.3.10. Ophthalmology
15.6.5.3.11. Respiratory Diseases
15.6.5.3.12. Vaccines
15.6.5.3.13. Others
15.6.5.4. South Africa Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.5.4.1. Medical Research Centers
15.6.5.4.2. Pharmaceutical Manufacturers
15.6.5.4.3. Biotechnology Companies
15.6.5.4.4. Government Institutions
15.6.5.4.5. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Healthcare
Clinical Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Services
15.6.6.1.1. Clinical Trials Execution
15.6.6.1.2. Statistical Analytics
15.6.6.1.3. Pharmacovigilance Services
15.6.6.1.4. Regulatory Submissions
15.6.6.1.5. Data Management
15.6.6.1.6. Medical Writing
15.6.6.1.7. Others
15.6.6.2. Rest of Middle East & Africa Healthcare
Clinical Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.6.2.1. Drug Discovery
15.6.6.2.2. Clinical Trial Phases
15.6.6.2.2.1. Preclinical
15.6.6.2.2.2. Phase I
15.6.6.2.2.3. Phase II
15.6.6.2.2.4. Phase III/ Pivotal
15.6.6.2.2.5. FDA Approval
15.6.6.2.3. Regulatory Affairs
15.6.6.2.4. Risk
Management
15.6.6.2.5. Others
15.6.6.3. Rest of Middle East & Africa Healthcare
Clinical Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Therapeutic Area
15.6.6.3.1. Cardiovascular
15.6.6.3.2. Dermatology
15.6.6.3.3. Gastroenterology
15.6.6.3.4. Oncology
15.6.6.3.5. Infectious Diseases
15.6.6.3.6. Immunology
15.6.6.3.7. Neurology
15.6.6.3.8. Urology
15.6.6.3.9. Pharmacology
15.6.6.3.10. Ophthalmology
15.6.6.3.11. Respiratory Diseases
15.6.6.3.12. Vaccines
15.6.6.3.13. Others
15.6.6.4. Rest of Middle East & Africa Healthcare
Clinical Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By End
Users
15.6.6.4.1. Medical Research Centers
15.6.6.4.2. Pharmaceutical Manufacturers
15.6.6.4.3. Biotechnology Companies
15.6.6.4.4. Government Institutions
15.6.6.4.5. Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Services
15.7.3. By Application
15.7.4. By Therapeutic Area
15.7.5. By End Users
16. Latin America Healthcare Clinical Research
Outsourcing Market Analysis and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn)
16.2. Latin America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
16.2.1. Clinical Trials Execution
16.2.2. Statistical Analytics
16.2.3. Pharmacovigilance Services
16.2.4. Regulatory Submissions
16.2.5. Data Management
16.2.6. Medical Writing
16.2.7. Others
16.3. Latin America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
16.3.1. Drug Discovery
16.3.2. Clinical Trial Phases
16.3.2.1. Preclinical
16.3.2.2. Phase I
16.3.2.3. Phase II
16.3.2.4. Phase III/ Pivotal
16.3.2.5. FDA Approval
16.3.3. Regulatory Affairs
16.3.4. Risk
Management
16.3.5. Others
16.4. Latin America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
16.4.1. Cardiovascular
16.4.2. Dermatology
16.4.3. Gastroenterology
16.4.4. Oncology
16.4.5. Infectious Diseases
16.4.6. Immunology
16.4.7. Neurology
16.4.8. Urology
16.4.9. Pharmacology
16.4.10. Ophthalmology
16.4.11. Respiratory Diseases
16.4.12. Vaccines
16.4.13. Others
16.5. Latin America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Medical Research Centers
16.5.2. Pharmaceutical Manufacturers
16.5.3. Biotechnology Companies
16.5.4. Government Institutions
16.5.5. Others
16.6. Latin America Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
16.6.1.1.1. Clinical Trials Execution
16.6.1.1.2. Statistical Analytics
16.6.1.1.3. Pharmacovigilance Services
16.6.1.1.4. Regulatory Submissions
16.6.1.1.5. Data Management
16.6.1.1.6. Medical Writing
16.6.1.1.7. Others
16.6.1.2. Brazil Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.2.1. Drug Discovery
16.6.1.2.2. Clinical Trial Phases
16.6.1.2.2.1. Preclinical
16.6.1.2.2.2. Phase I
16.6.1.2.2.3. Phase II
16.6.1.2.2.4. Phase III/ Pivotal
16.6.1.2.2.5. FDA Approval
16.6.1.2.3. Regulatory Affairs
16.6.1.2.4. Risk
Management
16.6.1.2.5. Others
16.6.1.3. Brazil Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
16.6.1.3.1. Cardiovascular
16.6.1.3.2. Dermatology
16.6.1.3.3. Gastroenterology
16.6.1.3.4. Oncology
16.6.1.3.5. Infectious Diseases
16.6.1.3.6. Immunology
16.6.1.3.7. Neurology
16.6.1.3.8. Urology
16.6.1.3.9. Pharmacology
16.6.1.3.10. Ophthalmology
16.6.1.3.11. Respiratory Diseases
16.6.1.3.12. Vaccines
16.6.1.3.13. Others
16.6.1.4. Brazil Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.1.4.1. Medical Research Centers
16.6.1.4.2. Pharmaceutical Manufacturers
16.6.1.4.3. Biotechnology Companies
16.6.1.4.4. Government Institutions
16.6.1.4.5. Others
16.6.2. Argentina
16.6.2.1. Argentina Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
16.6.2.1.1. Clinical Trials Execution
16.6.2.1.2. Statistical Analytics
16.6.2.1.3. Pharmacovigilance Services
16.6.2.1.4. Regulatory Submissions
16.6.2.1.5. Data Management
16.6.2.1.6. Medical Writing
16.6.2.1.7. Others
16.6.2.2. Argentina Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.2.1. Drug Discovery
16.6.2.2.2. Clinical Trial Phases
16.6.2.2.2.1. Preclinical
16.6.2.2.2.2. Phase I
16.6.2.2.2.3. Phase II
16.6.2.2.2.4. Phase III/ Pivotal
16.6.2.2.2.5. FDA Approval
16.6.2.2.3. Regulatory Affairs
16.6.2.2.4. Risk
Management
16.6.2.2.5. Others
16.6.2.3. Argentina Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
16.6.2.3.1. Cardiovascular
16.6.2.3.2. Dermatology
16.6.2.3.3. Gastroenterology
16.6.2.3.4. Oncology
16.6.2.3.5. Infectious Diseases
16.6.2.3.6. Immunology
16.6.2.3.7. Neurology
16.6.2.3.8. Urology
16.6.2.3.9. Pharmacology
16.6.2.3.10. Ophthalmology
16.6.2.3.11. Respiratory Diseases
16.6.2.3.12. Vaccines
16.6.2.3.13. Others
16.6.2.4. Argentina Healthcare Clinical Research
Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.2.4.1. Medical Research Centers
16.6.2.4.2. Pharmaceutical Manufacturers
16.6.2.4.3. Biotechnology Companies
16.6.2.4.4. Government Institutions
16.6.2.4.5. Others
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Services
16.6.3.1.1. Clinical Trials Execution
16.6.3.1.2. Statistical Analytics
16.6.3.1.3. Pharmacovigilance Services
16.6.3.1.4. Regulatory Submissions
16.6.3.1.5. Data Management
16.6.3.1.6. Medical Writing
16.6.3.1.7. Others
16.6.3.2. Rest of Latin America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.2.1. Drug Discovery
16.6.3.2.2. Clinical Trial Phases
16.6.3.2.2.1. Preclinical
16.6.3.2.2.2. Phase I
16.6.3.2.2.3. Phase II
16.6.3.2.2.4. Phase III/ Pivotal
16.6.3.2.2.5. FDA Approval
16.6.3.2.3. Regulatory Affairs
16.6.3.2.4. Risk
Management
16.6.3.2.5. Others
16.6.3.3. Rest of Latin America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
16.6.3.3.1. Cardiovascular
16.6.3.3.2. Dermatology
16.6.3.3.3. Gastroenterology
16.6.3.3.4. Oncology
16.6.3.3.5. Infectious Diseases
16.6.3.3.6. Immunology
16.6.3.3.7. Neurology
16.6.3.3.8. Urology
16.6.3.3.9. Pharmacology
16.6.3.3.10. Ophthalmology
16.6.3.3.11. Respiratory Diseases
16.6.3.3.12. Vaccines
16.6.3.3.13. Others
16.6.3.4. Rest of Latin America Healthcare Clinical
Research Outsourcing Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Medical Research Centers
16.6.3.4.2. Pharmaceutical Manufacturers
16.6.3.4.3. Biotechnology Companies
16.6.3.4.4. Government Institutions
16.6.3.4.5. Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Services
16.7.3. By Application
16.7.4. By Therapeutic Area
16.7.5. By End Users
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. Accell Clinical Research, LLC
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. CMIC Holdings Co, LTD.
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Covance Inc.
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. ICON plc
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. IQVIA Inc.
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Javara
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. KCR S.A.
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Marietta Eye Clinic.
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Parexel International Corporation
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. PPD Inc.
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. PSI
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. Syneos Health
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. WuXi AppTec
18.13.1. Company Details
18.13.2. Company Overview
18.13.3. Product Offerings
18.13.4. Key Developments
18.13.5. Financial Analysis
18.13.6. SWOT Analysis
18.13.7. Business Strategies
18.14. Other Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
